Delivery Order SPE2DB22D2206-SPE2DB24FEQ48
Award Date 12/14/23
Potential Completion Date 1/8/24
Potential Value $4.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has received a $5,075.88 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply ZOLADEX 10.8 MG IMPLANT SYRNS. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the DLA by November 29, 2023 from its headquarters in Conshohocken, Pennsylvania. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, routinely supports DLA Troop Support Medical programs through the provision...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,782.64 Firm Fixed Price Delivery Order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a type of pharmaceutical product, with a ceiling value of $5,263.74. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a potential value of $3,509.16 and a completion date of January 31, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to provide...
- This federal contract award, valued at $2,379.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,607,277 ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed price and a period of performance through September 17, 2024. AmerisourceBergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,297.50, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a firm fixed price and ultimate completion date of February 5, 2025. This award is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,564.32, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is February 7, 2025. This award is part of a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a ceiling value of $10,527.36 and a performance period through April 18, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency awarded a $5,076 delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will provide the pharmaceutical products to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from August 16 to September 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,564,891,329 units of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS. The contract has a ceiling value of $1,249.20 and is a firm fixed price Delivery Order with a completion date of July 1, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds significant Indefinite...